Myoscience said it landed $8.4 million of a hoped-for $11.5 million for a device that applies extreme cold to the skin as a way to temporarily treat pain and smooth wrinkles.
Funding Roundup
UPDATE: Cohealo reports $9m Series A round for medical device sharing software
Silicon Valley Bank’s Ben Johnson talks early-stage medtech investment slump | Medtech funding for the week of September 22, 2014
What’s behind the slump in early-stage medtech investment?
Vital Therapies looks to tap the market for $46M more
Vital Therapies (NSDQ:VTL) registered a $46 million public stock offering for its technique for the regeneration of liver tissue.
Palmaz Scientific uncorks more funding
Palmaz Scientific recorded $1.3 million of a planned $4.2 million funding round for the prosthetic implant technology it’s developing in Dallas.
Minerva Surgical’s just an inch away from closing a $25.5M round
California women’s health company Minerva Surgical is just a stone’s throw from wrapping up an equity funding round slated to bring in $25.6 million.
Breast implant maker Sientra registers an $86M IPO
California medical device maker Sientra Inc. is looking to hit the public markets with an initial public offering that could raise as much as $86.3 million, according to an SEC filing.
Ivantis adds $25M, eyes U.S. approval for glaucoma micro-stent
Ivantis today said it added a $25 million tranche to its now $71 million Series B round as the Irvine, Calif.-based company looks to bring its miniature glaucoma scaffold to the U.S. market.
Diabetes: iHealth realigns, eyes the globe with new $25M investment
California mobile devices maker iHealth is undergoing a major shift, fueled by a $25 million investment from Xiaomi Ventures, the company’s 1st institutional round of funding.